This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Mayo Foundation for Medical Education and Research, Oregon Health & Science University. Active years: 2015-2016.
Company Filing History:
2 out of 1,805 
2 out of 524 
Years Active: 2015-2016
Title: Joseph Lillegard: Innovator in Genetic Research
Introduction
Joseph Lillegard is a notable inventor based in Rochester, MN (US). He has made significant contributions to the field of genetic research, particularly in the development of animal models for studying human diseases. With a total of 2 patents, his work has implications for both research and therapeutic applications.
Latest Patents
Lillegard's latest patents focus on the creation of Fumarylacetoacetate hydrolase (Fah)-deficient pigs. These pigs are generated through homologous recombination and somatic cell nuclear transfer. The Fah-deficient pigs can be utilized for various research and therapeutic purposes, including the expansion of human hepatocytes and serving as large animal models for hereditary tyrosinemia type 1, cirrhosis, and hepatocellular carcinoma.
Career Highlights
Throughout his career, Joseph Lillegard has worked with esteemed institutions such as Oregon Health & Science University and the Mayo Foundation for Medical Education and Research. His innovative approaches have positioned him as a key figure in the field of genetic research.
Collaborations
Some of his notable coworkers include Markus Grompe and Scott Nyberg. Their collaborative efforts have further advanced the research in genetic engineering and therapeutic applications.
Conclusion
Joseph Lillegard's contributions to genetic research through his innovative patents and collaborations highlight his importance in the scientific community. His work continues to pave the way for advancements in medical research and therapeutic solutions.